Core Insights - Shanghai has approved a total of 30 domestically developed Class 1 innovative drugs from 2021 to September 2025, leading the nation in drug and medical device innovation [1] - The Shanghai government is committed to accelerating the entire chain of biopharmaceutical innovation, including basic research, incubation, clinical trials, regulatory approval, production, and application [1] - The establishment of various funds, including a 225 billion yuan biopharmaceutical industry mother fund and a 150 billion yuan future industry fund, aims to support long-term investments in the biopharmaceutical sector [3][4] Investment and Funding - The Shanghai National Investment Biopharmaceutical Industry Ecosystem Cooperation Fund was signed during the event, emphasizing the importance of patient capital in the high-risk, high-investment biopharmaceutical industry [2] - As of October 2023, the total investment decision in biopharmaceutical sub-funds by the Shanghai biopharmaceutical mother fund and other funds has reached approximately 6.6 billion yuan, with a market selection of 22 sub-funds [4] - The funds focus on innovative drug and medical device supply chains, brain-computer interfaces, synthetic biology, and other cutting-edge technologies [4] Industry Development - The Zhangjiang Pharma Valley has approved 30 Class 1 innovative drugs and 37 innovative medical devices, showcasing significant progress in the biopharmaceutical sector [9] - The Shanghai region has attracted over 50% of the capital for the biopharmaceutical industry, facilitating both research and commercialization efforts [9] - The connection between original innovation and application is emphasized, with institutions acting as bridges to transition basic research into viable drug products [10] Future Directions - The focus for the next 5-10 years will be on transforming original innovation capabilities into drug forms, which is seen as a critical development direction [10] - A comprehensive service center has been established to support the entire process from idea generation to approval and industrialization [10]